Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Mirum Pharmaceuticals Inc
F:08D
Mirum Pharmaceuticals Inc
F:08D
Price:
68.72
EUR
-2.44%
Market Closed
Market Cap:
€3.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Mirum Pharmaceuticals Inc
F:08D
|
US |
|
J
|
Jeronimo Martins SGPS SA
DUS:JEM
|
PT |
|
W
|
Waves Home Appliances Ltd
KAR:WAVESAPP
|
PK |
|
P
|
Pakistan Synthetics Ltd
KAR:PSYL
|
PK |
|
CI Games SA
F:CI7
|
PL |
Wall St Price Targets
08D Price Forecast
Based on 17 analysts
Based on 17 analysts
+40% Upside
from
€68.72
today
Mirum Pharmaceuticals Inc (08D)’s 12-month stock price forecast through October 2027 has a consensus target of €96.24, implying 40% upside. The forecast is based on price targets from 17 Wall Street analysts.
08D Analyst Rating
No ratings yet
No ratings yet
Mirum Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 08D's stock price target?
Price Target
96.24
EUR
96.24
EUR
According to Wall Street analysts, the average 1-year price target for 08D is 96.24 EUR with a low forecast of 85.76 EUR and a high forecast of 137.99 EUR.
What is the Revenue forecast for Mirum Pharmaceuticals Inc?
Projected CAGR
21%
21%
The compound annual growth rate for Revenue over the next 8 years is 21%.
What is the Gross Profit forecast for Mirum Pharmaceuticals Inc?
Projected CAGR
22%
22%
The compound annual growth rate for Gross Profit over the next 8 years is 22%.